BRAF V600 mutations and pathological features in Japanese melanoma

被引：0
|
作者：
Yamazaki, N. [1 ]
Tanaka, R. [1 ]
Tsutsumida, A. [1 ]
Namikawa, K. [1 ]
Eguchi, H. [1 ]
Omata, W. [1 ]
Oashi, K. [1 ]
Tsuta, K. [2 ]
机构：
[1] Natl Canc Ctr, Chuo Ku, Tokyo, Japan
[2] Natl Canc Ctr, Pathol & Clin Labs, Chuo Ku, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3758
引用
收藏
页码：S874 / S874
页数：1
相关论文
共 50 条
  • [41] Quantitative assessment of BRAF V600 mutant cell-free tumor DNA from plasma as a diagnostic and therapeutic biomarker in pts with BRAF V600 mutant melanoma
    Schreuer, Max
    Meersseman, Geert
    Jansen, Yanina
    Seremet, Teofila
    Chevolet, Ines
    Bott, Ambre
    Wilgenhof, Sofie
    Maertens, Geert
    Neyns, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Use of Cobas 4800 BRAF mutation test for the analysis of BRAF V600 mutations in cytological samples (CS) from metastatic melanoma (MM)
    Martin-Algarra, Salvador
    Labiano, Tania
    Ignacio Echeveste, Jose
    Gomez, Nerea
    Montanana, Myriam
    Aguirre, Mercedes
    Eugenia Echarri, Maria
    Sanmamed, Miguel F.
    Gurpide, Alfonso
    Luis Perez-Gracia, Jose
    Idoate, Miguel A.
    Lozano, Maria D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] VEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION
    Haanen, J. B. A. G.
    Scholtens, A.
    Geukes, M.
    van Thienen, H.
    van Tinteren, H.
    ANNALS OF ONCOLOGY, 2014, 25
  • [44] Intrapatient homogeneity of BRAF V600 status in melanoma with the exception of sentinel lymph node
    Nardin, C.
    Puzenat, E.
    Doussot, A.
    Pretet, J. L.
    Algros, M. P.
    Deveza, E.
    Adotevi, O.
    Aubin, F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB171 - AB171
  • [45] The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence
    Lemech, Charlotte
    Infante, Jeffrey
    Arkenau, Hendrik-Tobias
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2012, 4 (02) : 61 - 73
  • [46] Comparison of different testing methods for detection of BRAF V600 mutation in metastatic melanoma
    Hernandez-Losa, J.
    Ruano, Y.
    Trigo Sanchez, I.
    Somoza, R.
    Ferrer, B.
    Garcia Verdes-Montenegro, F.
    Urech, M.
    Ramon Y Cajal, S.
    Rios Martin, J. J.
    Rodriguez-Peralto, J. L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [47] Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience
    Arance, A. M.
    Berrocal, A.
    Lopez-Martin, J. A.
    de la Cruz-Merino, L.
    Soriano, V.
    Martin Algarra, S.
    Alonso, L.
    Cerezuela, P.
    La Orden, B.
    Espinosa, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (11): : 1147 - 1157
  • [48] BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods
    O'Brien, Odharnaith
    Lyons, Tomas
    Murphy, Sandra
    Feeley, Linda
    Power, Derek
    Heffron, Cynthia C. B. B.
    JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (11) : 935 - 940
  • [49] Vemurafenib for BRAF V600 mutated advanced melanoma: Results of treatment beyond progression
    Scholtens, A.
    Foppen, M. H. Geukes
    Blank, C. U.
    van Thienen, J. V.
    van Tinteren, H.
    Haanen, J. B.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (05) : 642 - 652
  • [50] Detection of BRAF V600 Mutations in Melanoma: Evaluation of Concordance between the Cobas® 4800 BRAF V600 Mutation Test and the Methods Used in French National Cancer Institute (INCa) Platforms in a Real-Life Setting
    Mourah, Samia
    Denis, Marc G.
    Narducci, Fabienne Escande
    Solassol, Jerome
    Merlin, Jean-Louis
    Sabourin, Jean-Christophe
    Scoazec, Jean-Yves
    Ouafik, L'Houcine
    Emile, Jean-Francois
    Heller, Remy
    Souvignet, Claude
    Bergougnoux, Loic
    Merlio, Jean-Philippe
    PLOS ONE, 2015, 10 (03):
12345